Background Advances in diagnostic and therapeutic strategies in oncology have
significantly increased the chance of survival of cancer patients, even those with metastatic …

Alzheimer's disease (AD) dementia is the most common form of dementia, comprising 60 to
70 percent of all cases. AD is a progressive neurodegenerative disease that causes memory …

The increasing use of eHealth has ushered in a new era of patient-centred cancer care that
moves beyond the traditional in-person care model to real-time, dynamic, and technology …

Cancer-related cognitive impairment (CRCI) is a frequent side effect experienced by an
increasing number of cancer survivors with a significant impact on their quality of life …

One in three people will be diagnosed with cancer during their lifetime. The community of
cancer patients is growing, and several common cancers are becoming increasingly …

Sex or gender differences in the risk of Alzheimer's disease and related dementias (ADRD)
differ by world region, suggesting that there are potentially modifiable risk factors for …

Importance A growing body of evidence supports a link between androgen deprivation
therapy (ADT) and cognitive dysfunction, including Alzheimer disease. However, it is …

Importance The use of second-generation antiandrogens (AAs) in the treatment of prostate
cancer is increasing. Retrospective evidence suggests an association between second …

Background Androgen deprivation therapy (ADT) is the backbone of systemic therapy for
men with prostate cancer (PC); almost one-half of patients receive treatment during their …

Alzheimer's disease (AD) is a neurodegenerative disease responsible for almost half of all
dementia cases in the world and progressively increasing. The etiopathology includes …